FOXP3 and graft versus host disease: In humans, Kanakry et al. 27reported a favorable CD4+, CD8+ and CD4+CD25+Foxp3+ T‐cell reconstitution after Allo‐HCT with bone marrow grafts and PTCy as a single agent for GvHD prophylaxis.